🤑 It doesn’t get more affordable. Grab this 60% OFF Black Friday offer before it disappears…CLAIM SALE

House Approves GOP Spending Package To Include Medical Marijuana Access For Veterans

Published 04/06/2024, 23:54
Updated 05/06/2024, 01:10
© Reuters.  House Approves GOP Spending Package To Include Medical Marijuana Access For Veterans

Benzinga - by Maureen Meehan, Benzinga Editor.

U.S. Congresspersons Earl Blumenauer (D-Ore.), Brian Mast (R-Fla.), Dave Joyce (R-Ohio) and Barbara Lee (D-Calif.) successfully passed their bipartisan amendment in the Republicans' Veterans Affairs spending package.

This amendment would end the Department of Veterans Affairs (VA) prohibition on assisting veterans in accessing medical marijuana.

VA policy currently prevents providers from recommending, making referrals or completing forms for medical marijuana, regardless of whether the state the veteran resides in has legalized it for medical use.

"One of the most painful vestiges of the failed war on drugs is the continued denial of the therapeutic properties of cannabis," said Blumenauer in a press release shared with Benzinga.

Blumenaur is the founder and co-chair of the Congressional Cannabis Caucus. "Nowhere is this more apparent than at the VA, which use to hand out opioids like Tic-Tacs but bars providers from even discussing a far safer alternative to treat chronic pain, PTSD, anxiety and depression: medical cannabis."

Mast agreed. "As I was recovering in Walter Reed, I was put on a laundry list of prescription medications. Thankfully, I was able to quit those cold turkey, but not everyone can do the same. Our veteran population is facing multiple epidemics, including addiction and suicide, and we owe it to them to make sure they've got every tool possible in the arsenal to deal with the impacts of battle — that includes medical cannabis."

Joyce, the son of a World War II veteran, said he was proud to join his colleagues to help veterans access medical treatment.

“We should all be resolved to help expand access to treatments for the medical challenges — both mental and physical — our nation's veterans experience. I am glad to see this amendment pass the House to help eliminate barriers for alternative treatments and provide our veterans with the care they need to overcome the wounds of war," Joyce said.

Also a co-chair of the caucus, Lee wrapped up the comments.

"As we continue experiencing the throes of the opioid crisis ravaging communities across the countries — from urban centers to rural areas — the hands of VA physicians should not be tied when it comes to advising around medical treatments that are scientifically proven to be less harmful and addictive, like state-legal medical marijuana. I am proud to co-lead this amendment and thank my fellow Cannabis Caucus Co-Chairs Mast, Blumenauer and Joyce for their partnership on this important matter," Lee said.

The amendment, which passed the House 290-116, would prohibit funds appropriated for the VA in fiscal year 2025 from being used to enforce the agency's anti-marijuana policy. The amendment is based on Blumenauer and Mast's Veterans Equal Access Act.

Photo: Shutterstock

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.